{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T03:38:24Z","timestamp":1793417904036,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Youth Program of the National Natural Science Foundation of China","award":["No. 82100222"],"award-info":[{"award-number":["No. 82100222"]}]},{"name":"the Henan Province Medical Science and Technology Project Constructed by the Provincial and Ministerial Departments, PR China","award":["No. SBGJ202303005"],"award-info":[{"award-number":["No. SBGJ202303005"]}]},{"name":"the Henan Province Medical Science and Technology Tackling Program Joint Co-construction Project, PR China","award":["No. LHGJ20230023"],"award-info":[{"award-number":["No. LHGJ20230023"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14737-1","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T10:50:00Z","timestamp":1756291800000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Identification of the IFN-\u03b3\/IL-4 ratio as a prognostic biomarker and development of an immune-related prognostic model in diffuse large B-cell lymphoma"],"prefix":"10.1186","volume":"25","author":[{"given":"Pan","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunmeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suqiong","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohang","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongjun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zunmin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,27]]},"reference":[{"issue":"3","key":"14737_CR1","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/s41375-024-02503-4","volume":"39","author":"Q Cui","year":"2025","unstructured":"Cui Q, Tan W, Song B, Peng RJ, Wang L, Dorajoo R, Ng KP, Lin GW, Au WY, Liang RHS, Khor CC, Zhang QL, Foo JN, Li SP, Zhang FR, Zhang XJ, Yu XQ, Lan Q, Chanock S, Jia WH, Lim ST, Li WY, Rothman N, Bei JX, Liu J, Lin D, Liu JJ. Genetic susceptibility of diffuse large B-cell lymphoma: a meta genome-wide association study in Asian population. Leukemia. 2025;39(3):694\u2013702. https:\/\/doi.org\/10.1038\/s41375-024-02503-4.","journal-title":"Leukemia"},{"issue":"2","key":"14737_CR2","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.critrevonc.2012.12.009","volume":"87","author":"M Martelli","year":"2013","unstructured":"Martelli M, Ferreri AJ, Agostinelli C, Di Rocco A, Pfreundschuh M, Pileri SA. Diffuse large B-cell lymphoma. Crit Rev Oncol Hematol. 2013;87(2):146\u201371. https:\/\/doi.org\/10.1016\/j.critrevonc.2012.12.009.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"11","key":"14737_CR3","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1093\/annonc\/mdu109","volume":"25","author":"R Vaidya","year":"2014","unstructured":"Vaidya R, Witzig TE. Prognostic factors for diffuse large B-cell lymphoma in the R(X)CHOP era. Ann Oncol. 2014;25(11):2124\u201333. https:\/\/doi.org\/10.1093\/annonc\/mdu109.","journal-title":"Ann Oncol"},{"issue":"23","key":"14737_CR4","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1182\/blood.2019002729","volume":"135","author":"AS Ruppert","year":"2020","unstructured":"Ruppert AS, Dixon JG, Salles G, Wall A, Cunningham D, Poeschel V, Haioun C, Tilly H, Ghesquieres H, Ziepert M, Flament J, Flowers C, Shi Q, Schmitz N. International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI. Blood. 2020;135(23):2041\u20138. https:\/\/doi.org\/10.1182\/blood.2019002729.","journal-title":"Blood"},{"issue":"5","key":"14737_CR5","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1182\/blood-2006-08-038257","volume":"109","author":"LH Sehn","year":"2007","unstructured":"Sehn LH, Berry B, Chhanabhai M, Fitzgerald C, Gill K, Hoskins P, Klasa R, Savage KJ, Shenkier T, Sutherland J, Gascoyne RD. Connors: the revised international prognostic index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP. Blood. 2007;109(5):1857\u201361. https:\/\/doi.org\/10.1182\/blood-2006-08-038257.","journal-title":"Blood"},{"issue":"6","key":"14737_CR6","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1182\/blood-2013-09-524108","volume":"123","author":"Z Zhou","year":"2014","unstructured":"Zhou Z, Sehn LH, Rademaker AW, Gordon LI, Lacasce AS, Crosby-Thompson A, Vanderplas A, Zelenetz AD, Abel GA, Rodriguez MA, Nademanee A, Kaminski MS, Czuczman MS, Millenson M, Niland J, Gascoyne RD, Connors JM, Friedberg JW. Winter: an enhanced international prognostic index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. Blood. 2014;123(6):837\u201342. https:\/\/doi.org\/10.1182\/blood-2013-09-524108.","journal-title":"Blood"},{"issue":"5","key":"14737_CR7","doi-asserted-by":"publisher","first-page":"e561","DOI":"10.1038\/bcj.2017.43","volume":"7","author":"Y Kusano","year":"2017","unstructured":"Kusano Y, Yokoyama M, Terui Y, Nishimura N, Mishima Y, Ueda K, Tsuyama N, Yamauchi H, Takahashi A, Inoue N, Takeuchi K, Hatake K. Low absolute peripheral blood CD4\u2009+\u2009T-cell count predicts poor prognosis in R-CHOP-treated patients with diffuse large B-cell lymphoma. Blood Cancer J. 2017;7(5):e561. https:\/\/doi.org\/10.1038\/bcj.2017.43.","journal-title":"Blood Cancer J"},{"issue":"3","key":"14737_CR8","doi-asserted-by":"publisher","first-page":"718","DOI":"10.3324\/haematol.2019.243626","volume":"106","author":"M Autio","year":"2021","unstructured":"Autio M, Leivonen SK, Bruck O, Mustjoki S, Meszaros Jorgensen J, Karjalainen-Lindsberg ML, Beiske K, Holte H, Pellinen T, Leppa S. Immune cell constitution in the tumor microenvironment predicts the outcome in diffuse large B-cell lymphoma. Haematologica. 2021;106(3):718\u201329. https:\/\/doi.org\/10.3324\/haematol.2019.243626.","journal-title":"Haematologica"},{"issue":"4","key":"14737_CR9","doi-asserted-by":"publisher","first-page":"e558","DOI":"10.1038\/bcj.2017.37","volume":"7","author":"Y Kusano","year":"2017","unstructured":"Kusano Y, Yokoyama M, Terui Y, Nishimura N, Mishima Y, Ueda K, Tsuyama N, Yamauchi H, Takahashi A, Inoue N, Takeuchi K, Hatake K. Low absolute peripheral blood CD4\u2009+\u2009T-cell count predicts poor prognosis in R-CHOP-treated patients with diffuse large B-cell lymphoma. Blood Cancer J. 2017;7(4):e558. https:\/\/doi.org\/10.1038\/bcj.2017.37.","journal-title":"Blood Cancer J"},{"issue":"2","key":"14737_CR10","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.clml.2016.11.005","volume":"17","author":"J Judd","year":"2017","unstructured":"Judd J, Dulaimi E, Li T, Millenson MM, Borghaei H, Smith MR, Al-Saleem T. Low level of blood CD4(+) T cells is an independent predictor of inferior Progression-free survival in diffuse large B-cell lymphoma. Clin Lymphoma Myeloma Leuk. 2017;17(2):83\u20138. https:\/\/doi.org\/10.1016\/j.clml.2016.11.005.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"14737_CR11","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1182\/blood-2023-178327","volume":"142","author":"H-Y Wang","year":"2023","unstructured":"Wang H-Y, Yang F-C, Yang C-F, Tsai C-K, Ko P-S, Liu Y-C, Chen N-J. Ratio of Circulating CD8\u2009+\u2009T lymphocytes to M-MDSCs (CD8MMR): A novel prognostic predictor for Treatment-Na\u00efve DLBCL patients. Blood. 2023;142:1763.","journal-title":"Blood"},{"issue":"12","key":"14737_CR12","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.7150\/jca.50552","volume":"12","author":"F Gao","year":"2021","unstructured":"Gao F, Hu J, Zhang J, Xu Y. Prognostic value of peripheral blood lymphocyte\/monocyte ratio in lymphoma. J Cancer. 2021;12(12):3407\u201317. https:\/\/doi.org\/10.7150\/jca.50552.","journal-title":"J Cancer"},{"issue":"21","key":"14737_CR13","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1182\/blood.V116.21.991.991","volume":"116","author":"SM Ansell","year":"2010","unstructured":"Ansell SM, Maurer MJ, Ziesmer SC, Slager SL, Habermann TM, Link B, Witzig TE, Cerhan J, Novak AJ. Pretreatment serum cytokines predict early disease relapse and a poor prognosis in diffuse large B-cell lymphoma (DLBCL) patients. Blood. 2010;116(21):991.","journal-title":"Blood"},{"key":"14737_CR14","doi-asserted-by":"publisher","first-page":"156289","DOI":"10.1016\/j.cyto.2023.156289","volume":"169","author":"C Bao","year":"2023","unstructured":"Bao C, Gu J, Huang X, You L, Zhou Z, Jin J. Cytokine profiles in patients with newly diagnosed diffuse large B-cell lymphoma: IL-6 and IL-10 levels are associated with adverse clinical features and poor outcomes. Cytokine. 2023;169:156289. https:\/\/doi.org\/10.1016\/j.cyto.2023.156289.","journal-title":"Cytokine"},{"issue":"10","key":"14737_CR15","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1007\/s00262-001-0232-8","volume":"50","author":"T Mori","year":"2001","unstructured":"Mori T, Takada R, Watanabe R, Okamoto S, Ikeda Y. T-helper (Th)1\/Th2 imbalance in patients with previously untreated B-cell diffuse large cell lymphoma. Cancer Immunol Immunother. 2001;50(10):566\u20138. https:\/\/doi.org\/10.1007\/s00262-001-0232-8.","journal-title":"Cancer Immunol Immunother"},{"key":"14737_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115976","volume":"170","author":"Q Shang","year":"2024","unstructured":"Shang Q, Yu X, Sun Q, Li H, Sun C, Liu L. Polysaccharides regulate Th1\/Th2 balance: a new strategy for tumor immunotherapy. Biomed Pharmacother. 2024;170: 115976. https:\/\/doi.org\/10.1016\/j.biopha.2023.115976.","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"14737_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13030373","volume":"13","author":"T Accogli","year":"2021","unstructured":"Accogli T, Bruchard M, Vegran F. Modulation of CD4 T cell response according to tumor cytokine microenvironment. Cancers (Basel). 2021;13(3): 373. https:\/\/doi.org\/10.3390\/cancers13030373.","journal-title":"Cancers (Basel)"},{"issue":"17","key":"14737_CR18","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.1002\/cncr.30740","volume":"123","author":"JL Koff","year":"2017","unstructured":"Koff JL, Flowers CR. Prognostic modeling in diffuse large B-cell lymphoma in the era of immunochemotherapy: where do we go from here? Cancer. 2017;123(17):3222\u20135. https:\/\/doi.org\/10.1002\/cncr.30740.","journal-title":"Cancer"},{"issue":"1","key":"14737_CR19","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s12935-021-01978-w","volume":"21","author":"H Hou","year":"2021","unstructured":"Hou H, Luo Y, Tang G, Zhang B, Ouyang R, Wang T, Huang M, Wu S, Li D, Wang F. Dynamic changes in peripheral blood lymphocyte subset counts and functions in patients with diffuse large B cell lymphoma during chemotherapy. Cancer Cell Int. 2021;21(1):282. https:\/\/doi.org\/10.1186\/s12935-021-01978-w.","journal-title":"Cancer Cell Int"},{"key":"14737_CR20","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.bcmd.2016.04.004","volume":"59","author":"M Rusak","year":"2016","unstructured":"Rusak M, Bolkun L, Chociej-Stypulkowska J, Pawlus J, Kloczko J, Dabrowska M. Flow-cytometry-based evaluation of peripheral blood lymphocytes in prognostication of newly diagnosed DLBCL patients. Blood Cells Mol Dis. 2016;59:92\u20136. https:\/\/doi.org\/10.1016\/j.bcmd.2016.04.004.","journal-title":"Blood Cells Mol Dis"},{"issue":"2","key":"14737_CR21","doi-asserted-by":"publisher","first-page":"S364","DOI":"10.1016\/j.jaci.2007.06.016","volume":"121","author":"DF LaRosa","year":"2008","unstructured":"LaRosa DF. Orange: 1. Lymphocytes. J Allergy Clin Immunol. 2008;121(2):S364\u20139.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"14737_CR22","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1182\/blood-2008-05-078154","volume":"112","author":"J Zhu","year":"2008","unstructured":"Zhu J, Paul WE. CD4 T cells: fates, functions, and faults. Blood. 2008;112(5):1557\u201369. https:\/\/doi.org\/10.1182\/blood-2008-05-078154.","journal-title":"Blood"},{"issue":"3","key":"14737_CR23","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.bbamcr.2015.11.003","volume":"1863","author":"NS Nicholas","year":"2016","unstructured":"Nicholas NS, Apollonio B, Ramsay AG. Tumor microenvironment (TME)-driven immune suppression in B cell malignancy. Biochim Biophys Acta. 2016;1863(3):471\u201382. https:\/\/doi.org\/10.1016\/j.bbamcr.2015.11.003.","journal-title":"Biochim Biophys Acta"},{"key":"14737_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15030835","author":"T Takahara","year":"2023","unstructured":"Takahara T, Nakamura S, Tsuzuki T, Satou A. The immunology of DLBCL. Cancers (Basel). 2023. https:\/\/doi.org\/10.3390\/cancers15030835.","journal-title":"Cancers (Basel)"},{"issue":"4","key":"14737_CR25","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/ajh.23398","volume":"88","author":"C Keane","year":"2013","unstructured":"Keane C, Gill D, Vari F, Cross D, Griffiths L, Gandhi M. CD4(+) tumor infiltrating lymphocytes are prognostic and independent of R-IPI in patients with DLBCL receiving R-CHOP chemo-immunotherapy. Am J Hematol. 2013;88(4):273\u20136. https:\/\/doi.org\/10.1002\/ajh.23398.","journal-title":"Am J Hematol"},{"issue":"2","key":"14737_CR26","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s00428-013-1519-9","volume":"464","author":"H Rajnai","year":"2014","unstructured":"Rajnai H, Heyning FH, Koens L, Sebestyen A, Andrikovics H, Hogendoorn PC, Matolcsy A, Szepesi A. The density of CD8\u2009+\u2009T-cell infiltration and expression of BCL2 predicts outcome of primary diffuse large B-cell lymphoma of bone. Virchows Arch. 2014;464(2):229\u201339. https:\/\/doi.org\/10.1007\/s00428-013-1519-9.","journal-title":"Virchows Arch"},{"issue":"3","key":"14737_CR27","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/s12185-018-2466-7","volume":"108","author":"Y Shi","year":"2018","unstructured":"Shi Y, Deng L, Song Y, Lin D, Lai Y, Zhou L, Yang L, Li X. CD3+\/CD8\u2009+\u2009T-cell density and tumoral PD-L1 predict survival irrespective of rituximab treatment in Chinese diffuse large B-cell lymphoma patients. Int J Hematol. 2018;108(3):254\u201366. https:\/\/doi.org\/10.1007\/s12185-018-2466-7.","journal-title":"Int J Hematol"},{"issue":"2","key":"14737_CR28","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s12253-010-9306-2","volume":"17","author":"L Gergely","year":"2011","unstructured":"Gergely L, Vancsa A, Miltenyi Z, Simon Z, Barath S, Illes A. Pretreatment T lymphocyte numbers are contributing to the prognostic significance of absolute lymphocyte numbers in B-cell non-Hodgkins lymphomas. Pathol Oncol Res. 2011;17(2):249\u201355. https:\/\/doi.org\/10.1007\/s12253-010-9306-2.","journal-title":"Pathol Oncol Res"},{"issue":"7","key":"14737_CR29","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1136\/jclinpath-2020-207048","volume":"75","author":"FE Laddaga","year":"2022","unstructured":"Laddaga FE, Ingravallo G, Mestice A, Tamma R, Perrone T, Maiorano E, Ribatti D, Specchia G, Gaudio F. Correlation between Circulating blood and microenvironment T lymphocytes in diffuse large B-cell lymphomas. J Clin Pathol. 2022;75(7):493\u20137. https:\/\/doi.org\/10.1136\/jclinpath-2020-207048.","journal-title":"J Clin Pathol"},{"issue":"3","key":"14737_CR30","doi-asserted-by":"publisher","first-page":"162","DOI":"10.5045\/br.2014.49.3.162","volume":"49","author":"JK Kim","year":"2014","unstructured":"Kim JK, Chung JS, Shin HJ, Song MK, Yi JW, Shin DH, Lee DS, Baek SM. Influence of NK cell count on the survival of patients with diffuse large B-cell lymphoma treated with R-CHOP. Blood Res. 2014;49(3):162\u20139. https:\/\/doi.org\/10.5045\/br.2014.49.3.162.","journal-title":"Blood Res"},{"key":"14737_CR31","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev-immunol-061020-053702","volume":"39","author":"C Dong","year":"2021","unstructured":"Dong C. Cytokine regulation and function in T cells. Annu Rev Immunol. 2021;39:51\u201376. https:\/\/doi.org\/10.1146\/annurev-immunol-061020-053702.","journal-title":"Annu Rev Immunol"},{"issue":"3","key":"14737_CR32","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1093\/intimm\/dxh050","volume":"16","author":"O Wurtz","year":"2004","unstructured":"Wurtz O, Bajenoff M, Guerder S. IL-4-mediated Inhibition of IFN-gamma production by CD4\u2009+\u2009T cells proceeds by several developmentally regulated mechanisms. Int Immunol. 2004;16(3):501\u20138. https:\/\/doi.org\/10.1093\/intimm\/dxh050.","journal-title":"Int Immunol"},{"key":"14737_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.669474","volume":"12","author":"A Basu","year":"2021","unstructured":"Basu A, Ramamoorthi G, Albert G, Gallen C, Beyer A, Snyder C, Koski G, Disis ML, Czerniecki BJ, Kodumudi K. Differentiation and regulation of T(H) cells: a balancing act for cancer immunotherapy. Front Immunol. 2021;12: 669474. https:\/\/doi.org\/10.3389\/fimmu.2021.669474.","journal-title":"Front Immunol"},{"issue":"18","key":"14737_CR34","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1182\/bloodadvances.2018019919","volume":"2","author":"H Arima","year":"2018","unstructured":"Arima H, Nishikori M, Otsuka Y, Kishimoto W, Izumi K, Yasuda K, Yoshimoto T. Takaori-Kondo: B cells with aberrant activation of Notch1 signaling promote Treg and Th2 cell-dominant T-cell responses via IL-33. Blood Adv. 2018;2(18):2282\u201395. https:\/\/doi.org\/10.1182\/bloodadvances.2018019919.","journal-title":"Blood Adv"},{"key":"14737_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.746577","volume":"11","author":"Z Li","year":"2021","unstructured":"Li Z, Yu F, Ye W, Mao L, Huang J, Shao Y, Yan J, Yu W, Jin J, Wang J. Clinical features and prognostic significance of NOTCH1 mutations in diffuse large B-cell lymphoma. Front Oncol. 2021;11: 746577. https:\/\/doi.org\/10.3389\/fonc.2021.746577.","journal-title":"Front Oncol"},{"issue":"2","key":"14737_CR36","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1080\/08820139.2020.1840583","volume":"51","author":"M Dehghani","year":"2022","unstructured":"Dehghani M, Ramzi M, Kalani M, Golmoghaddam H, Arandi N. Higher peripheral blood IFN-gamma-\/IL-4\u2009+\u2009Th2 lymphocytes are associated with lower rate of relapse in patients with lymphoma. Immunol Invest. 2022;51(2):452\u201363. https:\/\/doi.org\/10.1080\/08820139.2020.1840583.","journal-title":"Immunol Invest"},{"issue":"5","key":"14737_CR37","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.blre.2018.03.005","volume":"32","author":"JC Wight","year":"2018","unstructured":"Wight JC, Chong G, Grigg AP, Hawkes EA. Prognostication of diffuse large B-cell lymphoma in the molecular era: moving beyond the IPI. Blood. 2018;32(5):400\u201315. https:\/\/doi.org\/10.1016\/j.blre.2018.03.005.","journal-title":"Blood"},{"key":"14737_CR38","doi-asserted-by":"publisher","first-page":"8586354","DOI":"10.1155\/2019\/8586354","volume":"2019","author":"AI Cioroianu","year":"2019","unstructured":"Cioroianu AI, Stinga PI, Sticlaru L, Cioplea MD, Nichita L, Popp C, Staniceanu F. Tumor Microenvironment in Diffuse Large B-Cell Lymphoma: Role and Prognosis. Anal Cell Pathol (Amst). 2019;2019:8586354. https:\/\/doi.org\/10.1155\/2019\/8586354.","journal-title":"Anal Cell Pathol (Amst)"},{"key":"14737_CR39","doi-asserted-by":"publisher","unstructured":"Jimenez-Cortegana C, Palazon-Carrion N, Garcia-Sancho AM, Nogales-Fernandez E, Carnicero-Gonzalez F, Rios-Herranz E, de la Cruz-Vicente F, Rodriguez-Garcia G, Fernandez-Alvarez R, Rueda Dominguez A, Casanova-Espinosa M, Martinez-Banaclocha N, Guma-Padro J, Gomez-Codina J, Labrador J, Salar-Silvestre A, Rodriguez-Abreu D, Galvez-Carvajal L, Provencio M, Sanchez-Beato M, Guirado-Risueno M, Espejo-Garcia P, Lejeune M, Alvaro T, Sanchez-Margalet V, de la Cruz-Merino L. Spanish lymphoma oncology, C. the Spanish group for immunobiotherapy of, G. Spanish lymphoma oncology, C. the Spanish group for immunobiotherapy of, G. Spanish lymphoma oncology and C. the Spanish group for immunobiotherapy of: Circulating myeloid-derived suppressor cells and regulatory T cells as immunological biomarkers in refractory\/relapsed diffuse large B-cell lymphoma: translational results from the R2-GDP-GOTEL trial. J Immunother Cancer. 2021;9(6). https:\/\/doi.org\/10.1136\/jitc-2020-002323.","DOI":"10.1136\/jitc-2020-002323"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14737-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14737-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14737-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T18:27:24Z","timestamp":1757442444000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14737-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,27]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14737"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14737-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6562919\/v1","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,27]]},"assertion":[{"value":"30 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in compliance with the Helsinki Declaration and was approved by the Medical Ethical Committees of both the Henan Provincial People\u2019s Hospital (Zhengzhou University People\u2019s Hospital Zhengzhou University People\u2019s Hospital) and the First Affiliated Hospital of Zhengzhou University. Written informed consent to participate in the study was obtained from all the patients treated in the Henan Provincial People\u2019s Hospital (Zhengzhou University People\u2019s Hospital Zhengzhou University People\u2019s Hospital) and the First Affiliated Hospital of Zhengzhou University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1386"}}